SG10201914098YA - Chromosomal landing pads and related uses - Google Patents
Chromosomal landing pads and related usesInfo
- Publication number
- SG10201914098YA SG10201914098YA SG10201914098YA SG10201914098YA SG10201914098YA SG 10201914098Y A SG10201914098Y A SG 10201914098YA SG 10201914098Y A SG10201914098Y A SG 10201914098YA SG 10201914098Y A SG10201914098Y A SG 10201914098YA SG 10201914098Y A SG10201914098Y A SG 10201914098YA
- Authority
- SG
- Singapore
- Prior art keywords
- chromosomal
- landing pads
- specific
- gene
- integration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161516612P | 2011-04-05 | 2011-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201914098YA true SG10201914098YA (en) | 2020-02-27 |
Family
ID=46000358
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201602663RA SG10201602663RA (en) | 2011-04-05 | 2012-04-05 | Chromosomal landing pads and related uses |
SG2013074778A SG194118A1 (en) | 2011-04-05 | 2012-04-05 | Chromosomal landing pads and related uses |
SG10201914098YA SG10201914098YA (en) | 2011-04-05 | 2012-04-05 | Chromosomal landing pads and related uses |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201602663RA SG10201602663RA (en) | 2011-04-05 | 2012-04-05 | Chromosomal landing pads and related uses |
SG2013074778A SG194118A1 (en) | 2011-04-05 | 2012-04-05 | Chromosomal landing pads and related uses |
Country Status (9)
Country | Link |
---|---|
US (2) | US8980579B2 (ja) |
EP (1) | EP2694661A1 (ja) |
JP (2) | JP2014511697A (ja) |
KR (1) | KR101999410B1 (ja) |
CN (2) | CN105969807A (ja) |
AU (1) | AU2012240164A1 (ja) |
CA (1) | CA2832095A1 (ja) |
SG (3) | SG10201602663RA (ja) |
WO (1) | WO2012138887A1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2832095A1 (en) | 2011-04-05 | 2012-10-11 | The Scripps Research Institute | Chromosomal landing pads and related uses |
AU2014281472A1 (en) * | 2013-06-19 | 2016-01-21 | Sigma-Aldrich Co. Llc. | Targeted integration |
JP6668340B2 (ja) | 2014-10-23 | 2020-03-18 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 新規cho組込み部位およびその使用 |
EP3283617B1 (en) * | 2015-04-13 | 2021-02-17 | President and Fellows of Harvard College | Production and monitoring of metabolites in cells |
CL2016001661A1 (es) | 2016-06-29 | 2017-03-03 | Univ Chile | Promotor hibrido de ß-actina (de cricetulus griseus) y citomegalovirus (cmv), con región rica en dinucleótidos, citosina-guanina, vectores, líneas celulares, procedimiento para producir proteínas recombinantes. |
WO2018148196A1 (en) * | 2017-02-07 | 2018-08-16 | Sigma-Aldrich Co. Llc | Stable targeted integration |
EP3583121A1 (en) * | 2017-02-17 | 2019-12-25 | Lonza Ltd | Multi-site specific integration cells for difficult to express proteins |
GB201703418D0 (en) | 2017-03-03 | 2017-04-19 | Ge Healthcare Bio Sciences Ab | Method for cell line development |
WO2018195402A1 (en) | 2017-04-20 | 2018-10-25 | Egenesis, Inc. | Methods for generating genetically modified animals |
WO2018213353A1 (en) * | 2017-05-16 | 2018-11-22 | Cairn Biosciences, Inc. | Multiplex assay |
GB201712678D0 (en) * | 2017-08-07 | 2017-09-20 | Glaxosmithkline Biologicals Sa | Process for the manipulation of nucleic acids |
EP3837371A2 (en) * | 2018-08-18 | 2021-06-23 | Cairn Biosciences, Inc. | Stem cell derived lineage barcoding |
KR102655024B1 (ko) * | 2019-04-02 | 2024-04-04 | 추가이 세이야쿠 가부시키가이샤 | 표적 특이적인 외래 유전자의 도입 방법 |
CA3136659C (en) * | 2019-04-18 | 2024-06-18 | Sigma-Aldrich Co. Llc | Stable targeted integration |
CN114727592A (zh) * | 2019-10-09 | 2022-07-08 | 杰克逊实验室 | 高频率靶向动物转基因 |
GB202019484D0 (en) * | 2020-12-10 | 2021-01-27 | Univ Edinburgh | CHO cell modification |
CN118401659A (zh) | 2021-10-14 | 2024-07-26 | 阿西莫夫公司 | 整合酶、着陆架架构和包括其的工程化细胞 |
IL312487A (en) | 2021-11-09 | 2024-07-01 | Asimov Inc | Stable production systems for adeno-associated virus vector production |
CN113999873B (zh) * | 2021-12-31 | 2022-05-20 | 北京市疾病预防控制中心 | 一种基因修饰的非人动物的构建方法及其应用 |
WO2024211287A1 (en) * | 2023-04-03 | 2024-10-10 | Seagen Inc. | Production cell lines with targeted integration sites |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5175385A (en) | 1987-09-03 | 1992-12-29 | Ohio University/Edison Animal Biotechnolgy Center | Virus-resistant transgenic mice |
US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US20100168016A1 (en) * | 2007-04-11 | 2010-07-01 | The Jackson Laboratory | Diagnosis and treatment of diseases caused by misfolded proteins |
CA2832095A1 (en) | 2011-04-05 | 2012-10-11 | The Scripps Research Institute | Chromosomal landing pads and related uses |
-
2012
- 2012-04-05 CA CA2832095A patent/CA2832095A1/en not_active Abandoned
- 2012-04-05 EP EP12716865.6A patent/EP2694661A1/en not_active Withdrawn
- 2012-04-05 CN CN201610291074.4A patent/CN105969807A/zh active Pending
- 2012-04-05 JP JP2014503993A patent/JP2014511697A/ja active Pending
- 2012-04-05 SG SG10201602663RA patent/SG10201602663RA/en unknown
- 2012-04-05 WO PCT/US2012/032362 patent/WO2012138887A1/en active Application Filing
- 2012-04-05 US US13/440,661 patent/US8980579B2/en active Active - Reinstated
- 2012-04-05 SG SG2013074778A patent/SG194118A1/en unknown
- 2012-04-05 SG SG10201914098YA patent/SG10201914098YA/en unknown
- 2012-04-05 CN CN201280025685.4A patent/CN103597083B/zh not_active Expired - Fee Related
- 2012-04-05 KR KR1020137028897A patent/KR101999410B1/ko active IP Right Grant
- 2012-04-05 AU AU2012240164A patent/AU2012240164A1/en not_active Abandoned
-
2015
- 2015-02-12 US US14/620,478 patent/US10017786B2/en active Active
-
2017
- 2017-08-24 JP JP2017161272A patent/JP6441425B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
SG194118A1 (en) | 2013-11-29 |
CN105969807A (zh) | 2016-09-28 |
SG10201602663RA (en) | 2016-05-30 |
JP2014511697A (ja) | 2014-05-19 |
US20120258541A1 (en) | 2012-10-11 |
US8980579B2 (en) | 2015-03-17 |
US20150152437A1 (en) | 2015-06-04 |
CN103597083B (zh) | 2016-05-18 |
JP2018011602A (ja) | 2018-01-25 |
KR101999410B1 (ko) | 2019-07-11 |
WO2012138887A1 (en) | 2012-10-11 |
CA2832095A1 (en) | 2012-10-11 |
US10017786B2 (en) | 2018-07-10 |
EP2694661A1 (en) | 2014-02-12 |
AU2012240164A1 (en) | 2013-11-14 |
KR20140019430A (ko) | 2014-02-14 |
JP6441425B2 (ja) | 2018-12-19 |
CN103597083A (zh) | 2014-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201914098YA (en) | Chromosomal landing pads and related uses | |
SG10201808935WA (en) | Targeted modification of rat genome | |
MX2012004579A (es) | Recombinacion homologa en genoma nuclear de algas. | |
PH12019501346A1 (en) | Thermostable cas9 nucleases | |
TN2014000493A1 (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | |
MX365435B (es) | Metodos de modificacion de celulas huesped. | |
MX351043B (es) | Metodos para modificacion genomica. | |
WO2012112730A3 (en) | Compositions and methods for delivering nucleic acid to a cell | |
BR112012014080A2 (pt) | método para modificação do material genético, método para geração de um ácido nucleico, monômero de endonuclease efetora tal, método para geração de um aninal, método para geração de uma planta, método para recombinação genética direcionada, ácido nucleico, cassete de expressão e célula hospedeira | |
WO2009118524A3 (en) | Efficient insertion of dna into embryonic stem cells | |
WO2010099383A3 (en) | Compositions and methods for ex vivo hepatic nucleic acid delivery | |
WO2013066438A3 (en) | Evaluation and improvement of nuclease cleavage specificity | |
MX2014012994A (es) | Direccion transmitida por nucleasa con vectores de direccion grandes. | |
WO2010042749A3 (en) | Chimeric therapeutics, compositions, and methods for using same | |
IN2014MN02500A (ja) | ||
WO2010042751A3 (en) | Chimeric therapeutics, compositions, and methods for using same | |
MX2009006681A (es) | Composiciones y metodos para la expresion de acidos nucleicos. | |
WO2012075462A3 (en) | Methods and compositions for treatment of muscular dystrophy | |
WO2007030674A3 (en) | Use of nucleases to improve viability and enhance transgene expression in transfected cells | |
IN2014DN10123A (ja) | ||
MX2013007087A (es) | Promotor viral, truncamientos de este y metodos de uso. | |
WO2010042742A3 (en) | Chimeric therapeutics, compositions, and methods for using same | |
WO2010042743A3 (en) | Chimeric multiplexes, compositions, and methods for using same | |
WO2014006452A3 (en) | Rapid alkalinization factor peptides for delivery of nucleic acid molecules into cells | |
MX2013007086A (es) | Promotor viral, truncamientos de este y metodos de uso. |